Canton Strategic Holdings, a Nasdaq-listed company, will begin offering tokenized versions of its common stock on a permissioned trading venue via the Canton Network starting November 2, 2026. This issuer-sponsored tokenization means the company itself backs the digital shares, which carry the same rights as its traditional Nasdaq shares. The trading will use atomic settlement for secure, all-or-nothing transactions, potentially bypassing the usual 30-day regulatory notice period. If successful, this could set a precedent for onchain equity trading under the SEC's Innovation Exemption, offering investors continuous trading access and faster settlement, though the venue will be smaller and more controlled than Nasdaq.
Canton Strategic Holdings' plan for tokenized share trading provides context for digital asset markets. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Oct 29, 2026 21:22 WIB: Among 50 major cryptocurrencies priced on Pluang, 26 rose and 23 fell today. Notable movers include MANA (Decentraland) at Rp1.400 with a 1-day change of -1.96% and a Pluang order activity of 5% Sell / 95% Buy, FIL (Filecoin) at Rp16.434 with +1.88% and balanced order activity, and LUNC (Terra Classic) at Rp0,809 with -1.82% and predominantly sell orders at 90%.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
